ArticleNeuroImage. Clinical2024
The association of motor reserve and clinical progression in Parkinson's disease.
Article in NeuroImage. Clinical, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Cognitive and motor reserve in Parkinson's disease: Two sides of the same coin?Journal of neuropsychology · 2026Article
- Wearable Inertial Sensor Analysis of Turning Performance Reveals Motor Reserve Effects in Drug-Naïve Parkinson's Disease.Sensors (Basel, Switzerland) · 2026Article
- Physiotherapy interventions for balance impairments in Parkinson's disease: evidence from a systematic review and dose-response meta-analysis.NPJ Parkinson's disease · 2026Article
- Data-driven subtyping of early Parkinson's disease via mutual cross-attention fusion of EEG and dual-task gait features.NPJ Parkinson's disease · 2026Article
- Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease.Annals of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the association of motor reserve (MR) and clinical progression in Parkinson's disease.
methodsThis longitudinal study using data from the Parkinson's progression markers initiative. Patients with de novo PD who underwent dopamine transporter scans at baseline and finished at least five years clinical follow-up assessments (including motor, cognitive, and non-motor symptoms) were included. The individual MR of PD patients were estimated based on initial motor deficits and striatal dopamine depletion using a residual model. Linear mixed-effects models (LME) were performed to examine the associations of baseline MR and clinical progression.
resultsA total of 303 de novo PD patients were included and the mean follow-up time was 8.95 years. Results of LME models revealed that the baseline MR was associated with motor, cognitive, and non-motor symptoms in PD patients. There was a significant interaction between MR and disease duration for longitudinal changes in motor (p < 0.001), cognitive (p = 0.028) and depression symptoms (p = 0.014). PD patients with lower MR had a more rapid progression to postural instability and cognitive impairment compared with those with higher MR (p = 0.002 and p = 0.001, respectively).
conclusionsThe baseline MR of PD patients were associated with motor and non-motor symptoms and can predicted disease prognosis, suggesting that the initial MR in PD would be associated with the individual's capacity to cope with neurodegenerative process as well as comprehensive prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.